Preventing diseases in infants delivered via caesarean section
AssigneeN.V. Nutricia
InventorsJoachim Schmitt, Bernd Stahl, Jan Knol
Life of this patent
Estimating the term…
Abstract
The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.
Claims12
A method for treatment and/or prevention of atopic dermatitis, eczema, asthma, allergic rhinitis or allergic conjunctivitis, in infants delivered via caesarean section comprising administering within 3 months of birth to an infant in need thereof a composition comprising 0.5 to 75 g of non-digestible oligosaccharides per 100 g dry weight of the composition, wherein the non-digestible oligosaccharides comprise galacto-oligosaccharides having at least 50% of its saccharide units as galactose units.
A method for treatment and/or prevention of atopic dermatitis, eczema, asthma, allergic rhinitis or allergic conjunctivitis in infants delivered via caesarean section comprising administering to an infant within 3 months of birth via caesarean section a composition comprising:
- (a) 0.5 to 75 g of non-digestible oligosaccharides per 100 g dry weight of the composition, wherein the non-digestible oligosaccharides comprise galacto-oligosaccharides having at least 50% of its saccharide units as galactose units;
- and
- (b) Bifidobacterium breve.
Dependencies are inferred from the claim text.